开发基于PROTAC的EZH2抑制剂的治疗视野:最近的成果,比较分析和未来的前景
1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University Nasr City Cairo 11884 Egypt hamadaorganic@azhar.edu.eg.
RSC advances
|January 16, 2026
概括
针对EZH2 (增强Zeste同源2) 的新PROTAC通过降解蛋白质来改善癌症治疗,克服传统抑制剂的局限性. MS8847显示出强大的EZH2降解,为向蛋白质降解策略设定了基准.
科学领域:
- 表观遗传学和癌症治疗方法
- 药用化学和药物发现
- 分子生物学和药理学 分子生物学和药理学
背景情况:
- EZH2 (Zeste同源增强剂2) 是瘤抑制基因沉默中的关键表观遗传调节剂.
- 传统的EZH2抑制剂面临着一些挑战,例如不完整的目标接触和抵抗.
- 化向化体 (PROTACs) 是一种通过向蛋白质降解来抑制EZH2的新方法.
研究的目的:
- 审查最近在EZH2向PROTAC中取得的进展,这些PROTAC是在过去五年中开发的.
- 分析VHL,CRBN和cIAP招募PROTAC的设计原则,合成和药理资料.
- 突出关键化合物和结构-活性关系,以有效降解EZH2.
主要方法:
- 在过去五年中报告的针对EZH2的PROTACs的文献综述.
- 对酶抑制,细胞毒性和降解动力学的比较分析.
- 评估结构-活性关系,结合酶选择性和链接器优化.
主要成果:
- MS8847成为一种强大的EZH2降解剂 (DC50 = 34nM),表现出度和时间依赖的活性.
- 基于VHL (P3,P4) 和基于CRBN (U3i) 的PROTAC显示出强大的双重生化和细胞疗效.
- 结构-活性趋势和酶选择性被确定为优化PROTAC性能的关键.
结论:
- 针对EZH2的PROTAC提供了一个有希望的治疗策略,以克服传统抑制剂的局限性.
- 专注于新型链酶,选择性映射和计算建模的持续研究将完善PROTAC的效率.
- 通过PROTACs的向蛋白质降解预示着表观遗传癌症治疗的新时代.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:26Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
01:26Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:28Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K